Valuation : DexCom, Inc.

Market Cap 31.9B 27.42B 25.84B 23.55B 44.03B 3,034B 44.2B 306B 118B 1,547B 120B 117B 4,898B P/E 2026 *
33.6x
P/E 2027 * 28.3x
Enterprise Value 31.14B 26.77B 25.22B 22.98B 42.98B 2,962B 43.15B 298B 115B 1,510B 117B 114B 4,781B EV / Sales 2026 *
5.95x
EV / Sales 2027 * 5.32x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-1.10%
1 week-7.47%
Current month-8.42%
1 month-1.91%
3 months+7.81%
6 months+22.38%
Current year+25.92%
1 week 71.8
Extreme 71.8
77.8
1 month 71.8
Extreme 71.8
79.2
Current year 48.5
Extreme 48.5
79.2
1 year 46.88
Extreme 46.88
79.2
3 years 46.88
Extreme 46.88
131.88
5 years 46.88
Extreme 46.88
144.55
10 years 9.12
Extreme 9.125
144.55
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%-7.47% - - 31.9B
-0.27%-3.40%-20.40%+4.47% 183B
-0.54%-0.16%-1.18%+14.92% 118B
-0.42%-2.31%+8.55%+81.95% 61.96B
-0.49%-6.75%+11.83%+44.52% 50.6B
+0.98%-3.91%-6.15%-32.60% 48.78B
-0.77%-6.94%+7.54%-19.62% 31.9B
-1.84%-3.02% - - 30.44B
-0.24%-0.50%+33.10%-14.30% 23.77B
-2.51%-10.87%-14.66%+6.30% 22.26B
Average -0.72%-2.73%+2.33%+10.71% 63.39B
Weighted average by Cap. -0.49%-1.89%-4.32%+13.88%

Financials

2026 *2027 *
Net sales 5.23B 4.5B 4.24B 3.86B 7.22B 498B 7.25B 50.09B 19.37B 254B 19.63B 19.21B 803B 5.8B 4.99B 4.7B 4.28B 8.01B 552B 8.04B 55.55B 21.48B 281B 21.77B 21.3B 890B
Net income 974M 838M 789M 719M 1.34B 92.69B 1.35B 9.33B 3.61B 47.24B 3.66B 3.58B 150B 1.15B 988M 931M 848M 1.59B 109B 1.59B 11B 4.26B 55.71B 4.31B 4.22B 176B
Net Debt -761M -654M -617M -562M -1.05B -72.41B -1.05B -7.29B -2.82B -36.9B -2.86B -2.8B -117B -1.06B -912M -860M -784M -1.47B -101B -1.47B -10.17B -3.93B -51.47B -3.98B -3.9B -163B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-09-09 €72.40 -0.28% 22
26-09-08 €72.60 -2.42% 0
26-09-07 €74.40 -1.59% 0
26-09-04 €75.60 -1.82% 0
26-09-03 €77.00 -0.52% 0
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
84.53USD
Average target price
94.12USD
Spread / Average Target
+11.35%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!